In locally advanced gastric carcinomas that have invaded adjacent organs, the prognosis is poor. When combined resections are performed in T4 gastric cancers, a high morbidity rate is reported and it is inconclusive as to whether or not there is an improvement in the survival rate. We investigated surgical outcomes and analysed the prognostic factors for T4 gastric cancers.
Introduction
Gastric cancer is a second leading cause of death in the world, accounting 10% of newly diagnosed cancers. 1 Although gastric cancer mortality has markedly declined around the world, the overall 5-year survival rate for locally advanced gastric carcinoma patients is below 20% and it is approximately 30% for these who undergo surgery. Even after a curative resection, only 30-50% of patients are still alive after 5 years, with local and peritoneal recurrence being the main cause of treatment failure. 2 Surgical treatment for gastric carcinoma is currently considered as the best approach for achieving curative outcomes. 3 Lymph node metastasis, depth of invasion, and tumour invasion to adjacent organs (T4) are all believed to be independent prognostic factors for gastric carcinoma. 4 In locally advanced gastric cancer, especially when the adjacent organ is invaded (T4), the prognosis is known to be poor because curative resection is difficult and a high incidence of postoperative morbidity and mortality is reported in other studies. [5] [6] [7] [8] [9] It is unclear whether combined resection can improve the outcomes of surgery in patients with T4
gastric carcinoma, because it is difficult to completely eliminate whole invading lesions, and post-operative complications can sometimes be fatal. 5, 6, [8] [9] [10] Recently, the therapeutic role of palliative resection, namely non-curative resection for locally advanced gastric cancer has been debated in several study groups, and it is a problem more complicated in T4 gastric cancers. 7, [11] [12] [13] [14] [15] In this study, we retrospectively studied surgical outcomes and analysed the prognostic factors for T4 gastric cancer patients to investigate the significance of curative (R0) multi-organ resection and palliative, that is, non-curative surgical treatment.
Patients and Methods
From 1992 to 2000, 1499 gastric cancer patients underwent surgical treatment at the Department of Surgery in Korea University Hospital. Among these patients, 132 patients were diagnosed with clinical T4 gastric carcinoma (cT4) that invaded adjacent organs, and surgical treatment was performed. Of these patients, 56 cases (42.4%) were histologically proved to be T4 gastric carcinoma (pT4). According to the surgical therapeutic approaches, the patients were divided into three groups: 34 patients underwent combined other organ resections (group I), 45 patients received gastrectomy alone (group II), and resections were not performed but palliative gastrojejunostomy or intraperitoneal chemotherapy were performed in 53 patients (group III). Combined resection with curative intent was indicated for those patients with tumour invasion of adjacent organs without distant metastasis or peritoneal disseminations. Some palliative resections were performed in patients with impending obstruction or cancer bleeding signs that had resectable tumour burdens without extensive peritoneal disseminations. Among these three groups, the clinicopathologic variables, such as gender, age, type of gastrectomy, tumour location, gross tumour type, histologic type, lymph node stage and distant metastasis were examined and compared. M1 was defined as comprising distant organ metastasis, and advanced nodal involvement like para-aortic metastasis and peritoneal metastasis. The curative (R0) resection was defined as the complete removal of cancer tissue regardless of combined multi-organ resection with no residual tumour macroscopically or microscopically. The surgical outcomes such as post-operative morbidity and curability were also evaluated.
In our surgical department, standard D2 lymph node dissections were performed in curative resections and, in selected cases, more extensive lymph node dissection, such as D2 plus para-aortic lymph node dissection, was performed with curative intent. However, we usually performed D1 or lesser than D2 lymph node dissections in palliative cases. The prognostic factors for T4 gastric cancers were evaluated in univariate survival analysis, and Cox proportional multivariate survival analysis was performed to identify independent prognostic factors in these patients. The SPSS program version 13.0 for Windows (SPSS Inc, Chicago, IL, USA) was used for all statistical analyses. The chi-squared test was applied to evaluate the difference in the proportions in the three treatment groups. Analysis of variance (ANOVA) was used to evaluate continuous variables, and all data are expressed as means ± SD. The survival curves according to the surgical treatment were constructed using Kaplan-Meier method and compared using the log-rank test. Multivariate analyses were performed using the Cox proportional hazard regression model. A value of p < 0.05 was considered statistically significant.
Results

Clinicopathologic features and outcomes
The clinicopathologic features of the 132 patients according to treatment groups are depicted in Table 1 . The statistically significantly different factors were tumour location, Borrmann type, tumour size, M stage and peritoneal metastasis (Table 1 ). In group I and II patients, a total of 43 curative (R0) resections (32.6%) were performed. Twenty-six patients (76.5%) in group I were cured by means of combined organ resection, however, only 17 cases (37.8%) in group II were cured by gastrectomy alone. In group III, 23 patients received palliative gastrojejunostomy but we could not perform any operative procedures, and in 17 patients, intraperitoneal chemotherapy was done. Combined adjacent organ resection was performed in 34 cases in total (25%). The most common organ among these was the transverse colon (15 cases), and multi-organ resection was performed in 11 cases (Table 2) . During immediate post-operative periods, 14 cases of morbidity were reported in the study groups, and there were no significant differences according to the treatment groups (Table 3) . Also, no post-operative 30-day mortality was reported in our study groups.
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Prognostic factors and survival analysis
In univariate survival analyses, the statistically significant prognostic factors were histologic type, M stage, peritoneal metastasis, curability and treatment groups (Table 4) . In multivariate analyses with these factors, the independent significant prognostic factors were curability and treatment groups according to surgical approaches (Table 5) .
In survival analyses, the overall survival rate of all T4 patients was 27% at 3 years and 19.5% at 5 years. When the survival curves were compared according to the treatment groups, there was no definite survival difference between group I and group II, but a marked difference between group III and the resection groups (groups I and II) (Figure) .
Discussion
In this study, the significantly different clinicopathologic factors among the three treatment groups were tumour location, Borrmann type, tumour size, and M stage, especially peritoneal metastasis. In our study, the main tumour location was in the lower third in all three treatment groups of T4 gastric cancers. This was the common finding for T4 gastric cancer patients in Eastern countries, but in Western countries, a high incidence of proximal stomach and gastroesophageal junction tumour was reported in T4 gastric cancer patients. 16, 17 Also, in our study, diffuse tumour location and Borrmann type IV gastric cancer comprised a relatively large proportion in group III. This phenomenon could be explained by the high incidence of peritoneal seeding in Borrmann IV gastric cancer, that is, linitis plastica. 18 When gastroenterologic surgeons encounter disseminated peritoneal seeding in laparotomies, they usually do not perform resections, but rather palliative procedures including bypass surgery (gastrojejunostomy) and intraperitoneal chemotherapy. 19, 20 Therefore, the proportion of cases with localised (P1) and disseminated (P2) peritoneal seeding was relatively low in groups I and II when compared to group III. Occasionally, we performed gastrectomy in localised cases for palliative treatment, but the result was poor. In some reports, tumour size in gastric cancer has been shown to be a significant prognostic factor, and large gastric cancers with diameter more than 8 cm have more aggressive behaviour and frequent peritoneal recurrences. 21, 22 In our study groups, the average diameter of the tumours in group III was about 8.3 cm, which corresponds to the criteria of a large gastric cancer; therefore, the rate of distant metastasis, including peritoneal dissemination, was higher than in the other groups and statistically different compared with the other groups. In this study, we performed combined multi-organ resection in 34 cases in group I, comprising 25% of all cases, and curative resections were performed in 26 patients (76.5%). Interestingly, 17 patients (37.8%) in group II could acquire curability by way of gastrectomy alone. Although the gastric cancer was found to have invaded adjacent organs in laparotomy (cT4), the final pathologic result was not (pathological T3), therefore accurate peri-operative gastric cancer staging is a difficult problem. 11, 23 In fact, other studies 6, 23 reported that pathological T4 was confirmed in 38-56% of cases after combined resection was performed in clinical T4 gastric cancers. These findings can be explained by the possibility that macroscopic invasion seen during operation is identified as inflammatory adhesion at the final pathologic analysis, and such a phenomenon might have occurred in group II in our cases. In group I, the most common combined organs resected were the transverse colon as well as the spleen and pancreas. In gastric cancers located in the middle and lower third, combined resection might be necessary to achieve curative goals when a cancer invades the posterior wall of the stomach, infiltrating the transverse colon and its mesocolon. There is a study reporting that patients with colon or mesocolon invasion had a significant survival advantage over those with other organ invasions in univariate analysis, however it was not a significant variable in the multivariate analysis. 24 Some other studies 10, 25 report the spleen and pancreas as the commonly resected adjacent organs, and we performed multi-organ resections in selected cases including splenectomies with distal pancreatectomies. When outcomes of patients who underwent gastrectomies alone, or together with splenectomies or pancreaticosplenectomies were retrospectively evaluated, the survival benefit was not demonstrated and overall complications including infectious complications were common. 26, 27 Dhar et al 24 proposed that removal of the spleen along with the organs invaded could produce the best outcome with an acceptable mortality in the treatment of T4 gastric carcinoma. We also performed gastrectomy along with pancreaticosplenectomy in selected cases and acquired curability with few post-operative problems.
In our series, a total of 14 postoperative complications (10.6%) were reported and no mortality was found. It was a strikingly favourable outcome when compared with other reports. 9, 10, 25 This favourable result could be explained by our study design which included patients who could not undergo gastrectomies but could undergo palliative procedures (group III) and suffered from minimal surgical stress. However, there was no significant difference in post-operative morbidity between resection and non-resection patients. Furthermore, there was no difference in post-operative morbidity between combined resection and the gastrectomy alone group. In other reports, mortality and morbidity rates associated with palliative resection have been shown not to be statistically significantly different from patients who underwent curative gastrectomy. 14 Based on these considerations, we suggest that extended gastrectomy with additional organ resection can be performed with minimal morbidity and can improve the chance of overall survival in patients with T4 gastric carcinoma. In our study groups, we achieved better surgical outcomes for T4 gastric cancers when curative resection was performed. When the surgical approaches were divided into three groups, en bloc resection of the carcinoma including gastrectomy with combined organ resection was shown to be a better surgical approach in locally advanced T4 gastric cancer patients. In our study, clinical data were retrospectively collected and analysed in an intention-to-treat manner. Therefore, better surgical outcomes could be achieved when curative resection was performed in which there might be the result of selection bias rather than surgical management.
Patients with far advanced gastric cancer are not commonly managed with surgical resection, and effective palliation can usually be accomplished with systemic chemotherapy, endoscopic stenting, or surgical bypass procedures.
14, 15 The importance of palliative resection in more advanced gastric cancer is still debated, especially in T4 and stage IV gastric cancers. 7, 14, 15 In recent reports, gastrectomy in addition to palliative resection proved to be valuable for achieving survival benefit in T4 gastric cancer patients. 7, 14, 15 In the present study, it is of interest to observe that multivariate analysis revealed that curative resection and the treatment group, according to the surgical approach, were significant independent prognostic factors, thus showing that the long-term surgical outcome for gastric carcinoma patients with adjacent invaded organs (T4) was better with resection than without resection. Although curative resection was not performed, palliative gastric resection can be applicable to such more advanced gastric cancer patients in terms of survival benefit and for a better quality of life. 
